Narrow search
Showing 1 - 10 of 1,229
Cover Image
The effect of intellectual property rights on domestic innovation in the pharmaceutical sector
Gamba, Simona - 2016
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …
Persistent link: https://www.econbiz.de/10011509446
Cover Image
The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry
Banerjee, Tannista; Siebert, Ralph - 2014
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10010229875
Cover Image
Private versus social incentives for pharmaceutical innovation
González, Paula; Macho-Stadler, Inés; … - 2015
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are "follow-on" drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct a...
Persistent link: https://www.econbiz.de/10011406575
Cover Image
Pharmaceutical innovation, longevity, and medical expenditure in Greece, 1995 - 2010
Lichtenberg, Frank - 2015
Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) - about 44% of the total increase in longevity … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …
Persistent link: https://www.econbiz.de/10010473542
Cover Image
Dynamic mergers effects on R&D investments and drug development across research phases in the pharmaceutical industry
Siebert, Ralph; Tian, Zhili - 2020
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms' internal drug development capability. We evaluate the effects of M&As on firms' post-merger R&D...
Persistent link: https://www.econbiz.de/10012219372
Cover Image
Patient mobility, health care quality and welfare
Brekke, Kurt R.; Levaggi, Rosella; Siciliani, Luigi; … - 2014
Patient mobility is a key issue in the EU who recently passed a new law on patients' right to EU-wide provider choice. In this paper we use a Hotelling model with two regions that differ in technology to study the impact of patient mobility on health care quality, health care financing and...
Persistent link: https://www.econbiz.de/10010229860
Cover Image
Modeling inter-regional patient mobility : does distance go far enough?
Irlacher, Michael; Pennerstorfer, Dieter; Renner, … - 2021
This paper estimates a theory-guided gravity equation of regional patient flows. In our model, a patient’s choice to consult a physician in a particular region depends on a measure of spatial accessibility that accounts for the exact locations of both patients and physicians. Introducing this...
Persistent link: https://www.econbiz.de/10012499616
Cover Image
Dynamic effects of licensing and knowledge transfer across research stages : evidence from the pharmaceutical industry
Tian, Zhili; Siebert, Ralph - 2020
In the pharmaceutical industry, firms frequently engage in licensing agreements to overcome innovation challenges and …
Persistent link: https://www.econbiz.de/10012219514
Cover Image
Dynamics of first-time patenting firms
Nilsen, Øivind Anti; Raknerud, Arvid - 2022
supports innovation activities, especially early in the life cycle of firms. …
Persistent link: https://www.econbiz.de/10013365124
Cover Image
The disciplinary effect of post-grant review : causal evidence from European patent opposition
Nagler, Markus; Sorg, Stefan - 2019
We study the causal impact of invalidating marginally valid patents during post-grant opposition at the European Patent Office on affected inventors' subsequent patenting. We exploit exogenous variation in invalidation by leveraging the participation of a patent's original examiner in the...
Persistent link: https://www.econbiz.de/10011996418